查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1478664

糖尿病神经病变治疗市场,占有率,规模,趋势,行业分析报告:依疾病类型,药物类别,分销管道,地区,细分市场,预测2024-2032年

Diabetic Neuropathy Treatment Market Share, Size, Trends, Industry Analysis Report, By Disorder Type; By Drug Class; By Distribution Channel; By Region; Segment Forecast, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 115 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的一项新研究，到 2032 年，全球糖尿病神经病变治疗市场规模预计将达到 95.7 亿美元。该报告提供了对当前市场动态的详细见解，并对未来市场成长进行了分析。

糖尿病神经病变是由糖尿病引起的神经损伤引起的，其特征是麻木、疼痛和无力等症状，影响多达一半的患者。有几个因素促进了糖尿病神经病变市场的成长。年轻人久坐的生活方式、不健康的饮食习惯和压力引起的肥胖会增加糖尿病神经病变的风险。此外，吸烟率上升和全球糖尿病盛行率上升等因素正在扩大神经病变治疗的潜在患者群体，并改变市场动态。

糖尿病盛行率的上升，加上人口老化和对糖尿病併发症认识的提高，正在推动对神经病变治疗的需求。新兴市场的治疗选择和治疗方法的发展将进一步支持市场扩张。此外，越来越多的老年人口易患糖尿病及其併发症，这增加了对神经病变治疗的需求。

政府提高人们对糖尿病认识和支持研发工作的措施也有助于市场扩张。週边神经病变包括多种与周围神经病变相关的疾病，随着世界人口老化和肥胖人口的增加，週边神经病变的情况进一步恶化。鑑于其与糖尿病的关联，糖尿病盛行率的上升预计将在预测期内推动市场成长。

随着糖尿病发生率的不断增加，糖尿病常见併发症—糖尿病神经病变的发生率也不断增加。盛行率的增加与对控制神经病理性症状和改善患者生活品质的有效治疗的需求不断增加直接相关。此外，医疗技术和药物研究的进步有助于开发专门针对糖尿病神经病变的创新疗法和药物，进一步推动市场成长。此外，人口老化的加剧以及肥胖和久坐生活方式等生活方式因素也促进了市场的扩张。

糖尿病神经病变治疗市场报告亮点

2023年，非类固醇抗发炎药（NSAIDs）细分市场在糖尿病神经病变治疗药物市场中占据最大市场占有率。非类固醇抗发炎药通常比处方药和医疗程序等其他治疗选择更便宜。

预计医院部门在预测期内将以最快的复合年增长率成长。与零售药局或其他医疗机构相比，医院药局可以获得更广泛的糖尿病神经病变药物。

2023年，北美市场占有率成长主要。该地区高昂的医疗费用，加上强大的保险覆盖范围和报销政策，确保患者能够获得广泛的糖尿病神经病变治疗。

预计亚太地区糖尿病神经病变治疗市场在预测期内复合年增长率将显着成长。在亚太地区，医疗保健专业人员和一般民众对糖尿病及其併发症（包括糖尿病神经病变）的认识不断提高。认识的提高将促使早期诊断、积极管理以及对治疗糖尿病神经病变药物的需求增加。

目录

第一章简介

第二章执行摘要

第三章研究方法论

第四章全球糖尿病神经病变治疗市场洞察

  • 药品类别快照
  • 糖尿病神经病变治疗市场动态
    • 驱动因素和机遇
      • 全球糖尿病的盛行率正在增加，预计市场成长将加速。
      • 主要参与者扩大研发活动以推动全球糖尿病神经病变市场
    • 限制因素和课题
      • 昂贵的药品预计将阻碍市场成长
  • PESTEL 分析
  • 糖尿病神经病变治疗市场的药物类别趋势
  • 价值链分析
  • COVID-19 影响分析

第五章全球糖尿病神经病变治疗市场：依疾病类型

  • 主要发现
  • 介绍
  • 週边神经神经病变
  • 自主神经病变
  • 近端神经神经病变
  • 局部神经病变

第六章全球糖尿病神经病变治疗市场：依通路

  • 主要发现
  • 介绍
  • 局部神经障碍
  • 诊所
  • 零售药店
  • 其他

第七章全球糖尿病神经病变治疗市场：依药物类别

  • 主要发现
  • 介绍
  • 辣椒素
  • 阿片类药物
  • 非类固醇类抗发炎药 (NSAID)
  • 抗忧郁药
  • 其他

第八章全球糖尿病神经病变治疗市场：依地区

  • 主要发现
  • 介绍
    • 糖尿病神经病变治疗市场评估：地区，2019-2032
  • 北美
    • 北美：依疾病类型，2019-2032
    • 北美：依药物类别，2019-2032
    • 北美：依通路划分，2019-2032
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲：依疾病类型分类，2019-2032
    • 欧洲：依药物类别，2019-2032
    • 欧洲：依通路划分，2019-2032
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
  • 亚太地区
    • 亚太地区：依疾病类型划分，2019-2032
    • 亚太地区：依药物类别，2019-2032
    • 亚太地区：依通路划分，2019-2032
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印度尼西亚
    • 韩国
  • 中东/非洲
    • 中东和非洲：依疾病类型分类，2019-2032
    • 中东和非洲：依药物类别划分，2019-2032 年
    • 中东和非洲：依分销管道划分，2019-2032
    • 沙乌地阿拉伯
    • 阿拉伯联合酋长国
    • 以色列
    • 南非
  • 拉丁美洲
    • 拉丁美洲：依疾病类型分类，2019-2032
    • 拉丁美洲：依药物类别划分，2019-2032
    • 拉丁美洲：依通路划分，2019-2032
    • 墨西哥
    • 巴西
    • 阿根廷

第9章 竞争格局

  • 扩张和收购分析
    • 扩张
    • 收购
  • 伙伴关係/协作/协议/揭露

第十章公司简介

  • Abbott
  • Astellas Pharma Inc
  • Boehringer Ingelheim GmbH
  • Eli Lilly and Company
  • Glenmark Pharmaceuticals Ltd
  • Janssen Pharmaceuticals, Inc
  • Lupin Pharmaceuticals
  • Medtronic PLC
  • Novartis
  • Pfizer. Inc
Product Code: PM4868

The global diabetic neuropathy treatment market size is expected to reach USD 9.57 billion by 2032, according to a new study by Polaris Market Research. The report "Diabetic Neuropathy Treatment Market Share, Size, Trends, Industry Analysis Report, By Disorder Type (Peripheral Neuropathy, Autonomic Neuropathy, Proximal Neuropathy, Focal Neuropathy); By Drug Class; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Diabetic neuropathy, resulting from nerve damage triggered by diabetes, is characterized by symptoms like numbness, pain, and weakness, affecting up to half of those with the condition. Several factors contribute to the growth of the diabetic neuropathy market. The sedentary lifestyle, unhealthy eating habits, and stress-induced obesity in younger individuals heighten the risk of developing diabetic neuropathy. Furthermore, factors like increased smoking rates and the global prevalence of diabetes expand the prospective patient pool for neuropathy treatments, altering market dynamics.

The rising prevalence of diabetes, combined with an aging population and increased awareness of diabetic complications, drives the demand for neuropathy treatments. Advancements in treatment options and therapeutic developments further propel market expansion. Additionally, the growing geriatric population, prone to diabetes and its complications, amplifies the need for neuropathy treatments.

Government initiatives to raise diabetes awareness and support research and development efforts also contribute to market growth. Peripheral neuropathy, which encompasses various conditions involving peripheral nerve damage, is exacerbated by the global rise in geriatric and obese populations. Given its association with diabetes, the escalating prevalence of diabetes is expected to drive market growth in the forecast period.

As diabetes continues to rise, so does the incidence of diabetic neuropathy, a common complication of the disease. This increasing prevalence directly correlates with a higher demand for effective treatments to manage neuropathic symptoms and improve patient's quality of life. Additionally, advancements in medical technology and pharmaceutical research contribute to the development of innovative therapies and medications tailored specifically for diabetic neuropathy, further driving market growth. Moreover, the growing aging population, coupled with lifestyle factors such as obesity and sedentary habits, contributes to the expanding market.

Diabetic Neuropathy Treatment Market Report Highlights

In 2023, the non-steroidal anti-inflammatory drugs (NSAIDs) segment accounted for the largest market share in the diabetic neuropathy treatment market. NSAIDs are generally more affordable compared to other treatment options, such as prescription medications or medical procedures.

The hospital segment is expected to grow at the fastest CAGR during the forecast period. Hospital pharmacies may have access to a broader range of diabetic neuropathy medications than retail pharmacies or other healthcare settings.

In 2023, North America accounted for the growth of a significant market share. The region's high healthcare expenditures, coupled with robust insurance coverage and reimbursement policies, ensure that patients have access to a wide range of diabetic neuropathy treatments.

The Asia Pacific region is expected for significant growth in CAGR during the forecast period in the diabetic neuropathy treatment market. There is a growing awareness of diabetes and its complications, including diabetic neuropathy, among healthcare professionals and the general population in the Asia Pacific region. Increased awareness leads to earlier diagnosis, proactive management, and a higher demand for diabetic neuropathy treatments.

The global key market players are Abbott, Astellas Pharma Inc., Boehringer Ingelheim GmbH, Eli Lilly and Company, Glenmark Pharmaceuticals Ltd, Janssen Pharmaceuticals, Inc., Lupin Pharmaceuticals, Medtronic PLC, Novartis, Pfizer. Inc.

Polaris Market Research has segmented the diabetic neuropathy treatment market report based on disorder type, drug class, distribution channel, and region.

Diabetic Neuropathy Treatment, Disorder Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Peripheral Neuropathy
  • Autonomic Neuropathy
  • Proximal Neuropathy
  • Focal Neuropathy

Diabetic Neuropathy Treatment, Drug Class Outlook (Revenue - USD Billion, 2019 - 2032)

  • Capsaicin
  • Opioid
  • Morphine
  • Others
  • Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
  • Ibuprofen
  • Naproxen
  • Others
  • Antidepressants
  • Tricyclic Antidepressants (TCAs)
  • Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Anticonvulsant Drugs
  • Other

Diabetic Neuropathy Treatment, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals
  • Clinics
  • Retail Pharmacies
  • Other

Diabetic Neuropathy Treatment, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Diabetic Neuropathy Treatment Market Insights

  • 4.1. Diabetic Neuropathy Treatment Market - Drug Class Snapshot
  • 4.2. Diabetic Neuropathy Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing prevalence of diabetes worldwide have been projected to spur market
      • 4.2.1.2. Growing research and development activities by key players to fuel the global diabetic neuropathy market
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High-cost medication is expected to hinder the growth of the market
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Diabetic Neuropathy Treatment Market Drug Class Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Diabetic Neuropathy Treatment Market, by Disorder Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • 5.3. Peripheral Neuropathy
    • 5.3.1. Global Diabetic Neuropathy Treatment Market, by Peripheral Neuropathy, by Region, 2019-2032 (USD Billion)
  • 5.4. Autonomic Neuropathy
    • 5.4.1. Global Diabetic Neuropathy Treatment Market, by Autonomic Neuropathy, by Region, 2019-2032 (USD Billion)
  • 5.5. Proximal Neuropathy
    • 5.5.1. Global Diabetic Neuropathy Treatment Market, by Proximal Neuropathy, by Region, 2019-2032 (USD Billion)
  • 5.6. Focal Neuropathy
    • 5.6.1. Global Diabetic Neuropathy Treatment Market, by Focal Neuropathy, by Region, 2019-2032 (USD Billion)

6. Global Diabetic Neuropathy Treatment Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 6.3. Focal Neuropathy
    • 6.3.1. Global Diabetic Neuropathy Treatment Market, by Focal Neuropathy, by Region, 2019-2032 (USD Billion)
  • 6.4. Clinics
    • 6.4.1. Global Diabetic Neuropathy Treatment Market, by Clinics, by Region, 2019-2032 (USD Billion)
  • 6.5. Retail Pharmacies
    • 6.5.1. Global Diabetic Neuropathy Treatment Market, by Retail Pharmacies, by Region, 2019-2032 (USD Billion)
  • 6.6. Other
    • 6.6.1. Global Diabetic Neuropathy Treatment Market, by Other, by Region, 2019-2032 (USD Billion)

7. Global Diabetic Neuropathy Treatment Market, by Drug Class

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • 7.3. Capsaicin
    • 7.3.1. Global Diabetic Neuropathy Treatment Market, by Capsaicin, By Region, 2019-2032 (USD Billion)
  • 7.4. Opioid
    • 7.4.1. Global Diabetic Neuropathy Treatment Market, by Opioid, By Region, 2019-2032 (USD Billion)
    • 7.4.2. Morphine
      • 7.4.2.1. Global Diabetic Neuropathy Treatment Market, by Morphine, By Region, 2019-2032 (USD Billion)
    • 7.4.3. Others
      • 7.4.3.1. Global Diabetic Neuropathy Treatment Market, by Others, By Region, 2019-2032 (USD Billion)
  • 7.5. Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
    • 7.5.1. Global Diabetic Neuropathy Treatment Market, by Non-Steroidal Anti-inflammatory Drugs (NSAIDs), By Region, 2019-2032 (USD Billion)
    • 7.5.2. Ibuprofen
      • 7.5.2.1. Global Diabetic Neuropathy Treatment Market, by Ibuprofen, By Region, 2019-2032 (USD Billion)
    • 7.5.3. Naproxen
      • 7.5.3.1. Global Diabetic Neuropathy Treatment Market, by Naproxen, By Region, 2019-2032 (USD Billion)
    • 7.5.4. Others
      • 7.5.4.1. Global Diabetic Neuropathy Treatment Market, by Others, By Region, 2019-2032 (USD Billion)
  • 7.6. Antidepressants
    • 7.6.1. Global Diabetic Neuropathy Treatment Market, by Antidepressants, By Region, 2019-2032 (USD Billion)
    • 7.6.2. Tricyclic Antidepressants (TCAs)
      • 7.6.2.1. Global Diabetic Neuropathy Treatment Market, by Tricyclic Antidepressants (TCAs), By Region, 2019-2032 (USD Billion)
    • 7.6.3. Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
      • 7.6.3.1. Global Diabetic Neuropathy Treatment Market, by Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs), By Region, 2019-2032 (USD Billion)
    • 7.6.4. Selective Serotonin Reuptake Inhibitors (SSRIs)
      • 7.6.4.1. Global Diabetic Neuropathy Treatment Market, by Selective Serotonin Reuptake Inhibitors (SSRIs), By Region, 2019-2032 (USD Billion)
    • 7.6.5. Anticonvulsant Drugs
      • 7.6.5.1. Global Diabetic Neuropathy Treatment Market, by Anticonvulsant Drugs, By Region, 2019-2032 (USD Billion)
  • 7.7. Other
    • 7.7.1. Global Diabetic Neuropathy Treatment Market, by Other, By Region, 2019-2032 (USD Billion)

8. Global Diabetic Neuropathy Treatment Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Diabetic Neuropathy Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Diabetic Neuropathy Treatment Market - North America
    • 8.3.1. North America: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
    • 8.3.3. North America: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.4. Diabetic Neuropathy Treatment Market - U.S.
      • 8.3.4.1. U.S.: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.5. Diabetic Neuropathy Treatment Market - Canada
      • 8.3.5.1. Canada: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.4. Diabetic Neuropathy Treatment Market - Europe
    • 8.4.1. Europe: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.4. Diabetic Neuropathy Treatment Market - UK
      • 8.4.4.1. UK: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.5. Diabetic Neuropathy Treatment Market - France
      • 8.4.5.1. France: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.6. Diabetic Neuropathy Treatment Market - Germany
      • 8.4.6.1. Germany: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.7. Diabetic Neuropathy Treatment Market - Italy
      • 8.4.7.1. Italy: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.8. Diabetic Neuropathy Treatment Market - Spain
      • 8.4.8.1. Spain: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.9. Diabetic Neuropathy Treatment Market - Netherlands
      • 8.4.9.1. Netherlands: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.10. Diabetic Neuropathy Treatment Market - Russia
      • 8.4.10.1. Russia: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.5. Diabetic Neuropathy Treatment Market - Asia Pacific
    • 8.5.1. Asia Pacific: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.4. Diabetic Neuropathy Treatment Market - China
      • 8.5.4.1. China: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.5. Diabetic Neuropathy Treatment Market - India
      • 8.5.5.1. India: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.6. Diabetic Neuropathy Treatment Market - Malaysia
      • 8.5.6.1. Malaysia: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.7. Diabetic Neuropathy Treatment Market - Japan
      • 8.5.7.1. Japan: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.8. Diabetic Neuropathy Treatment Market - Indonesia
      • 8.5.8.1. Indonesia: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.9. Diabetic Neuropathy Treatment Market - South Korea
      • 8.5.9.1. South Korea: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.6. Diabetic Neuropathy Treatment Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.4. Diabetic Neuropathy Treatment Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.5. Diabetic Neuropathy Treatment Market - UAE
      • 8.6.5.1. UAE: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.6. Diabetic Neuropathy Treatment Market - Israel
      • 8.6.6.1. Israel: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.7. Diabetic Neuropathy Treatment Market - South Africa
      • 8.6.7.1. South Africa: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.7. Diabetic Neuropathy Treatment Market - Latin America
    • 8.7.1. Latin America: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.4. Diabetic Neuropathy Treatment Market - Mexico
      • 8.7.4.1. Mexico: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.5. Diabetic Neuropathy Treatment Market - Brazil
      • 8.7.5.1. Brazil: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.6. Diabetic Neuropathy Treatment Market - Argentina
      • 8.7.6.1. Argentina: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Astellas Pharma Inc
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Boehringer Ingelheim GmbH
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Eli Lilly and Company
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Glenmark Pharmaceuticals Ltd
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Janssen Pharmaceuticals, Inc
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Lupin Pharmaceuticals
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Medtronic PLC
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Novartis
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Pfizer. Inc
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables

  • Table 1 Global Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 2 Global Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 3 Global Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 4 Diabetic Neuropathy Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 6 North America: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 7 North America: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 8 U.S.: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 10 U.S.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 11 Canada: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 13 Canada: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 14 Europe: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 16 Europe: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 17 UK: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 18 UK: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 19 UK: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 20 France: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 21 France: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 22 France: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 23 Germany: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 25 Germany: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 26 Italy: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 28 Italy: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 29 Spain: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 31 Spain: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 35 Russia: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 37 Russia: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 41 China: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 42 China: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 43 China: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 44 India: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 45 India: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 46 India: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 50 Japan: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 52 Japan: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 56 South Korea: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 58 South Korea: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 65 UAE: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 67 UAE: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 68 Israel: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 70 Israel: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 71 South Africa: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 73 South Africa: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 74 Latin America: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 76 Latin America: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 77 Mexico: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 79 Mexico: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 80 Brazil: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 82 Brazil: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 83 Argentina: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 85 Argentina: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Diabetic Neuropathy Treatment Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Distribution Channel
  • Figure 7. Global Diabetic Neuropathy Treatment Market, by Distribution Channel, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Disorder Type
  • Figure 9. Global Diabetic Neuropathy Treatment Market, by Disorder Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Drug Class
  • Figure 11. Global Diabetic Neuropathy Treatment Market, by Drug Class, 2022 & 2032 (USD Billion)
  • Figure 12. Diabetic Neuropathy Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Diabetic Neuropathy Treatment Market